← All Sponsors
SPONSOR

Shenzhen Shenxin Biotechnology Co., Ltd

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Respiratory Syncytial Virus Infections
NCT06645665 Phase 1
Recruiting

A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above

Respiratory Syncytial Virus Infections
China View Trial →